These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34889357)

  • 1. Evidence-Based Minireview: For overweight or obese persons with hemophilia A, should factor VIII dosing be based on ideal or actual body weight?
    Machin N; Lim MY
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):215-218. PubMed ID: 34889357
    [No Abstract]   [Full Text] [Related]  

  • 2. Continuous infusion of factor VIII concentrates in obese patients with severe haemophilia A: is weight-based dose-adjustment required?
    Boban A; Henrard S; Lambert C; Hermans C
    Haemophilia; 2016 Jan; 22(1):e62-4. PubMed ID: 26560746
    [No Abstract]   [Full Text] [Related]  

  • 3. Body Mass Index Best Predicts Recovery of Recombinant Factor VIII in Underweight to Obese Patients with Severe Haemophilia A.
    Tiede A; Cid AR; Goldmann G; Jiménez-Yuste V; Pluta M; Lissitchkov T; May M; Matytsina I; Miljic P; Pabinger I; Persson P
    Thromb Haemost; 2020 Feb; 120(2):277-288. PubMed ID: 31887776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic analysis of anti-hemophilic factor in the obese patient.
    Graham A; Jaworski K
    Haemophilia; 2014 Mar; 20(2):226-9. PubMed ID: 24252161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doses of Factor VIII for hemophilic bleeding.
    Weiss AE
    N Engl J Med; 1977 Dec; 297(22):1237-8. PubMed ID: 917065
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of being underweight or overweight on factor VIII dosing in hemophilia A patients.
    Henrard S; Speybroeck N; Hermans C
    Haematologica; 2013 Sep; 98(9):1481-6. PubMed ID: 23645693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New viewpoints in the treatment of hemophilia].
    Göbel U
    Dtsch Med Wochenschr; 1973 Sep; 98(39):1814-6. PubMed ID: 4583442
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemophilia A--complications and their treatment--illustrated by a case].
    Wagner W; Böcker R; Stute R
    MMW Munch Med Wochenschr; 1976 Mar; 118(10):291-2. PubMed ID: 817150
    [No Abstract]   [Full Text] [Related]  

  • 9. Duesberg and critics agree: hemophilia is the best test.
    Cohen J
    Science; 1994 Dec; 266(5191):1645-6. PubMed ID: 7992044
    [No Abstract]   [Full Text] [Related]  

  • 10. Setting the stage for individualized therapy in hemophilia: What role can pharmacokinetics play?
    Hazendonk HCAM; van Moort I; Mathôt RAA; Fijnvandraat K; Leebeek FWG; Collins PW; Cnossen MH;
    Blood Rev; 2018 Jul; 32(4):265-271. PubMed ID: 29426727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Substitution treatment in hemophilia. Critical measures and complications].
    Schimpf K
    Wien Med Wochenschr; 1977 Jun; 127(11):329-37. PubMed ID: 878496
    [No Abstract]   [Full Text] [Related]  

  • 12. Arthropathy and substitution therapy.
    Aledort LM
    Haemostasis; 1992; 22(5):245-6. PubMed ID: 1478534
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of self-therapy in hemophilia. A study of 72 patients with hemophilia A and B.
    Levine PH
    N Engl J Med; 1974 Dec; 291(26):1381-4. PubMed ID: 4427642
    [No Abstract]   [Full Text] [Related]  

  • 14. A continuing challenge: treatment of hemophilic children with acquired factor VIII inhibitors.
    Bell BA
    Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):105-6. PubMed ID: 8447549
    [No Abstract]   [Full Text] [Related]  

  • 15. [Factor VIII preparation].
    Mikami S
    Nihon Rinsho; 1981; 39(12):3680-7. PubMed ID: 6803033
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of Obesity in Young Patients with Severe Haemophilia and Its Potential Impact on Factor VIII Consumption in Germany.
    Olivieri M; Königs C; Heller C; Horneff S; Oldenburg J; Halimeh S; Kentouche K; Knöfler R; Fischer L; Pfrepper C; Kurnik K; Bidlingmaier C
    Hamostaseologie; 2019 Nov; 39(4):355-359. PubMed ID: 30722069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific therapy in hemophilia.
    Hutaff LW
    N C Med J; 1973 Mar; 34(3):193-6. PubMed ID: 4510809
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose requirement for replacement therapy in hemophilia A.
    Allain JP
    Thromb Haemost; 1979 Oct; 42(3):825-31. PubMed ID: 505399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor concentrate prophylaxis for neonates with hemophilia.
    Buchanan GR
    J Pediatr Hematol Oncol; 1999; 21(4):254-6. PubMed ID: 10445886
    [No Abstract]   [Full Text] [Related]  

  • 20. Massive factor-VIII infusion in Haemophiliac with factor-VIII inhibitor, high responder. 1977.
    Brackmann HH; Gormsen J
    Haemophilia; 2010 May; 16(102):2-3. PubMed ID: 20536980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.